These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 1721122)
1. Ninety-six episodes of spontaneous ventricular tachycardia in 1 week: success of ramp pacing by a pacer-cardioverter-defibrillator. Porterfield JG; Porterfield LM; Bray L Pacing Clin Electrophysiol; 1991 Oct; 14(10):1440-3. PubMed ID: 1721122 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [TBL] [Abstract][Full Text] [Related]
3. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. Leitch JW; Gillis AM; Wyse DG; Yee R; Klein GJ; Guiraudon G; Sheldon RS; Duff HJ; Kieser TM; Mitchell LB J Am Coll Cardiol; 1991 Jul; 18(1):145-51. PubMed ID: 2050917 [TBL] [Abstract][Full Text] [Related]
4. Holter documented sudden death in a patient with an implanted defibrillator. Birgersdotter-Green U; Rosenqvist M; Lindemans FW; Rydén L; Rådegran K Pacing Clin Electrophysiol; 1992 Jul; 15(7):1008-14. PubMed ID: 1378592 [TBL] [Abstract][Full Text] [Related]
5. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator. Ganjehei L; Nazeri A; Massumi A; Razavi M Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781 [TBL] [Abstract][Full Text] [Related]
6. The impact of antitachycardia pacing with defibrillation. Lüderitz B Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):312-6. PubMed ID: 1706844 [TBL] [Abstract][Full Text] [Related]
7. Improved patient surveillance and data acquisition with a third generation implantable cardioverter defibrillator. Luceri RM; Puchferran RL; Brownstein SL; Habal SM; David IB; Vardeman LL Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1870-4. PubMed ID: 1721191 [TBL] [Abstract][Full Text] [Related]
8. Device therapy for ventricular tachycardia or fibrillation: the implantable cardioverter defibrillator and antitachycardia pacing. Arteaga WJ; Drew BJ Crit Care Nurs Q; 1991 Aug; 14(2):60-71. PubMed ID: 2059870 [No Abstract] [Full Text] [Related]
9. Antitachycardia pacing and implantable cardioverter defibrillators. Furman S; Mercando AD Annu Rev Med; 1989; 40():123-36. PubMed ID: 2729924 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of an antitachycardia pacemaker and implantable defibrillator combination. Bonnet CA; Fogoros RN; Elson JJ; Fiedler SB; Burkholder JA Pacing Clin Electrophysiol; 1991 May; 14(5 Pt 1):814-22. PubMed ID: 1712959 [TBL] [Abstract][Full Text] [Related]
11. Tachycardia sensing failure of an implantable cardioverter defibrillator in a patient with hypertrophic cardiomyopathy. Grubb BP; Durzinsky D; Temesy-Armos P; Hahn H; Elliott L Pacing Clin Electrophysiol; 1992 Jun; 15(6):845-8. PubMed ID: 1376894 [TBL] [Abstract][Full Text] [Related]
12. Initial clinical experience with the pacemaker-cardioverter-defibrillator. Yee R; Klein GJ; Guiraudon GM; Jones DL; Sharma AD; Norris C Can J Cardiol; 1990 May; 6(4):147-56. PubMed ID: 2344560 [TBL] [Abstract][Full Text] [Related]
13. Determinants of pace-terminable ventricular tachycardia: implications for implantable antitachycardia devices. Ip JH; Winters SL; Schweitzer P; Lotvin A; Tepper D; Gomes AJ Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1777-81. PubMed ID: 1721174 [TBL] [Abstract][Full Text] [Related]
14. [Automatic implantable cardioverter-defibrillator (AICD) and antitachycardia pacemaker (Tachylog 651) in the treatment of ventricular tachyarrhythmias]. Gerckens U; Manz M; Funke HD; Kirchhoff PG; Lüderitz B Z Kardiol; 1987 Apr; 76(4):211-6. PubMed ID: 3604373 [TBL] [Abstract][Full Text] [Related]
15. Experience with a new implantable pacer-, cardioverter-defibrillator for the therapy of recurrent sustained ventricular tachyarrhythmias: a step toward a universal ventricular tachyarrhythmia control device. Fromer M; Schläpfer J; Fischer A; Kappenberger L Pacing Clin Electrophysiol; 1991 Aug; 14(8):1288-98. PubMed ID: 1719507 [TBL] [Abstract][Full Text] [Related]
16. Use of telemetry functions in the assessment of implanted antitachycardia device efficacy. Newman D; Dorian P; Downar E; Harris L; Cameron D; Waxman M; Hamilton R; Gow R; Hardy J Am J Cardiol; 1992 Sep; 70(6):616-21. PubMed ID: 1510010 [TBL] [Abstract][Full Text] [Related]